Arthu Línniker Lopes de Oliveira
Research Subjects
Arthu Línniker Lopes de Oliveira has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alvaro Perazzo
Universidade de São Paulo
2 shared publications - Arina Peixoto Nobre
Universidade de Fortaleza, Brasil
2 shared publications - Carlos Eduardo Lucena Montenegro
Universidade de Pernambuco, Brasil; Hospital Esperança Recife, Brasil
2 shared publications - Deuzenny Tenório
Instituto D’Or de Pesquisa e Ensino (IDOR), Rede D’Or
2 shared publications - Diana Patricia Lamprea Sepulveda
Universidade de Pernambuco
2 shared publications - Fabio Antonio Gaiotto
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Unidade de Transplante, Departamento de Cirurgia Cardiovascular
2 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Mudança dos Padrões da Mortalidade Fora do Hospital e da Perda Prematura de Vida em Cardiomiopatias: Um Estudo Nacional Baseado em População
Fundamento: As cardiomiopatias são uma importante causa de mortalidade cardiovascular, apresentando fenótipos dependentes da idade que variam desde morte súbita cardíaca (MSC) até insuficiência cardíaca progressiva. Apesar da queda nas taxas de mortalidade, lacunas na prevenção e no acesso a terapias avançadas podem se manifestar como mudanças no local do óbito e persistência de mortalidade prematura. Objetivos: Avaliar tendências temporais da mortalidade relacionada às cardiomiopatias no Brasil, examinar padrões etários no local do óbito e quantificar a mortalidade prematura por meio dos anos de vida perdidos (AVP). Métodos: Este estudo ecológico nacional, baseado em população, analisou 369 570 óbitos no Brasil (1996–2024) em que a cardiomiopatia (CID-10 I42) foi a causa básica. Tendências temporais foram avaliadas por regressão de Poisson, e associações entre idade e local do óbito foram estimadas por razões de chances (OR). Os AVP foram calculados utilizando tábuas de vida nacionais. Resultados: A mortalidade ajustada por idade diminuiu 1,7% ao ano (p<0,001). Óbitos hospitalares caíram de 75% para 43%, enquanto óbitos domiciliares aumentaram de 20% para 38%, com ponto de inflexão significativo por volta de 2011. Óbitos em vias públicas, usados como proxy de MSC, foram mais frequentes entre adultos de 20–39 anos (4,8%) do que entre aqueles com ≥60 anos (0,8%; OR 2,88; IC 95% 2,68–3,10). O total de AVP atingiu 6,83 milhões de anos. Indivíduos de 20–39 anos representaram apenas 5,5% dos óbitos, mas contribuíram com 12,8% dos AVP totais, com média de 42,9 anos perdidos por óbito. Conclusões: Apesar da queda na mortalidade, óbitos fora do ambiente hospitalar tornaram-se mais frequentes. O excesso de AVP entre adultos jovens evidencia lacunas na prevenção da MSC. Estratégias específicas por faixa etária são necessárias para reduzir a mortalidade prematura.
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessMudança dos Padrões da Mortalidade Fora do Hospital e da Perda Prematura de Vida em Cardiomiopatias: Um Estudo Nacional Baseado em População
Fundamento: As cardiomiopatias são uma importante causa de mortalidade cardiovascular, apresentando fenótipos dependentes da idade que variam desde morte súbita cardíaca (MSC) até insuficiência cardíaca progressiva. Apesar da queda nas taxas de mortalidade, lacunas na prevenção e no acesso a terapias avançadas podem se manifestar como mudanças no local do óbito e persistência de mortalidade prematura. Objetivos: Avaliar tendências temporais da mortalidade relacionada às cardiomiopatias no Brasil, examinar padrões etários no local do óbito e quantificar a mortalidade prematura por meio dos anos de vida perdidos (AVP). Métodos: Este estudo ecológico nacional, baseado em população, analisou 369 570 óbitos no Brasil (1996–2024) em que a cardiomiopatia (CID-10 I42) foi a causa básica. Tendências temporais foram avaliadas por regressão de Poisson, e associações entre idade e local do óbito foram estimadas por razões de chances (OR). Os AVP foram calculados utilizando tábuas de vida nacionais. Resultados: A mortalidade ajustada por idade diminuiu 1,7% ao ano (p<0,001). Óbitos hospitalares caíram de 75% para 43%, enquanto óbitos domiciliares aumentaram de 20% para 38%, com ponto de inflexão significativo por volta de 2011. Óbitos em vias públicas, usados como proxy de MSC, foram mais frequentes entre adultos de 20–39 anos (4,8%) do que entre aqueles com ≥60 anos (0,8%; OR 2,88; IC 95% 2,68–3,10). O total de AVP atingiu 6,83 milhões de anos. Indivíduos de 20–39 anos representaram apenas 5,5% dos óbitos, mas contribuíram com 12,8% dos AVP totais, com média de 42,9 anos perdidos por óbito. Conclusões: Apesar da queda na mortalidade, óbitos fora do ambiente hospitalar tornaram-se mais frequentes. O excesso de AVP entre adultos jovens evidencia lacunas na prevenção da MSC. Estratégias específicas por faixa etária são necessárias para reduzir a mortalidade prematura.
- Open Access
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Shifting Patterns of Out-Of-Hospital Mortality and Premature Life Loss in Cardiomyopathies: A Nationwide Population-Based Study
Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based [...] Abstract Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based
- 29 September 2026
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 6
Open AccessShifting Patterns of Out-Of-Hospital Mortality and Premature Life Loss in Cardiomyopathies: A Nationwide Population-Based Study
Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based [...] Abstract Background: Cardiomyopathies are a major cause of cardiovascular mortality, presenting age-dependent phenotypes ranging from sudden cardiac death (SCD) to progressive heart failure. Despite declining mortality rates, gaps in prevention and access to advanced therapies may manifest as shifts in the place of death and persistent premature mortality. Objectives: To evaluate temporal trends in cardiomyopathy-related mortality in Brazil, assess age-related patterns in the place of death, and quantify premature mortality through years of life lost (YLL). Methods: This nationwide, population-based
- Open Access
- 23 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (14)
Consequências neurológicas causadas pela SARS-CoV-2
Com a crise do novo coronavírus se tem diversas consequências a longo prazo para sociedade visto que centenas de países vivem em regime de distanciamento físico e isolamento social. Estudos comprovam também a existência de sintomas neurológicos em pacientes com COVID-19, tais como cefaleia, tontura e consciência prejudicada como o destaque, para as células do sistema nervoso central que podem ser infectadas juntamente com sistema respiratório. Trata-se de uma revisão integrativa de literatura, realizada conforme as etapas: elaboração da questão de pesquisa, levantamento bibliográfico, avaliação dos dados, análise dos dados e apresentação dos resultados. As bases de dados utilizadas foram Medical Literature Analysis and Retrieval System Online e Science Direct. A busca nas bases de dados resultou em 1.768 publicações, as quais foram selecionadas pelos critérios de elegibilidade, resultando na amostra final de 12 artigos. Foram identificados diferentes danos neurológicos associados a infecção por COVID-19, os quais possibilitam discussões sobre como essas consequências podem acontecer e quais os fatores envolvidos. Considera-se que os danos graves, estão mais presentes na população de grupo de risco, idosos e pessoas com comorbidades. Os estudos associados ás consequências da SARS-CoV-2 estão bastante direcionados aos cuidados e atenção ao sistema respiratório, o que promove um número mais reduzido de estudos direcionados ao sistema neurológico, contudo, há evidências, séries de casos e estudos que representam danos neurológicos pelo novo coronavírus. Assim, as manifestações neurológicas encontradas em pacientes com COVID-19 necessitam de assistência para auxiliar os provedores no tratamento, gerenciamento e reconhecimento nas complicações neurológica potencialmente fatais.
- 23 October 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (14)
Open AccessConsequências neurológicas causadas pela SARS-CoV-2
Com a crise do novo coronavírus se tem diversas consequências a longo prazo para sociedade visto que centenas de países vivem em regime de distanciamento físico e isolamento social. Estudos comprovam também a existência de sintomas neurológicos em pacientes com COVID-19, tais como cefaleia, tontura e consciência prejudicada como o destaque, para as células do sistema nervoso central que podem ser infectadas juntamente com sistema respiratório. Trata-se de uma revisão integrativa de literatura, realizada conforme as etapas: elaboração da questão de pesquisa, levantamento bibliográfico, avaliação dos dados, análise dos dados e apresentação dos resultados. As bases de dados utilizadas foram Medical Literature Analysis and Retrieval System Online e Science Direct. A busca nas bases de dados resultou em 1.768 publicações, as quais foram selecionadas pelos critérios de elegibilidade, resultando na amostra final de 12 artigos. Foram identificados diferentes danos neurológicos associados a infecção por COVID-19, os quais possibilitam discussões sobre como essas consequências podem acontecer e quais os fatores envolvidos. Considera-se que os danos graves, estão mais presentes na população de grupo de risco, idosos e pessoas com comorbidades. Os estudos associados ás consequências da SARS-CoV-2 estão bastante direcionados aos cuidados e atenção ao sistema respiratório, o que promove um número mais reduzido de estudos direcionados ao sistema neurológico, contudo, há evidências, séries de casos e estudos que representam danos neurológicos pelo novo coronavírus. Assim, as manifestações neurológicas encontradas em pacientes com COVID-19 necessitam de assistência para auxiliar os provedores no tratamento, gerenciamento e reconhecimento nas complicações neurológica potencialmente fatais.
- Open Access
- 1 May 2021
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 5 (Supplement) , A502-A503
Favorable Prognostics of Post-Exercise Irisine Released as Prophylaxis of Serious Covid-19 in Obese Elderly
Studies sought epidemiological profiles to establish risk groups for Covid-19’s evolution and discovered that the age group above 65 years old is one of the most severely affected, due to the presence of other comorbidities. In the USA approximately 55 million individuals are above that age range and more than 23 million are elderly obese individuals, alongside the high mortality rate in this population and lack of proven effective medicine against Covid-19, therapeutic alternatives against this disease are sought. With the occurrence of inflammatory pulmonary conditions increased by SARS-Cov-2 infection, irisin was indicated as having a potential preventive action. This peptide is secreted endogenously by striated skeletal muscles with fibronectin type III domain-containing protein 5 (FNDC5) proteolysis, when preceded by continued exercise of low to moderate intensity for more than 20 uninterrupted minutes. Regarding the weight variant, previous studies showed low levels of FNDC5 in people with excess fatty acids (in humans, adipose tissue divides into white, favoring the deposit of lipids, triglycerides and fat, more easily inflamed, and brown that stimulates thermogenesis). Among other functions, FNDC5 also stimulates the coactivator 1-alpha of PPAR gamma (PGC-1α) which corroborates with the uncoupling between the Uncoupling Protein 1 (UCP1) and the mitochondria. When UCP1 is disincorporated from this organelle, it becomes active and inhibits ATP synthesis, releasing heat, as well as favoring fatty acid oxidation and provides the mechanism of browning of white fat. After this conversion, irisin reduces ¼ of lipid accumulation present in the adipocyte by lipolysis, significantly increasing the levels of serum triglycerides and glycerols, as well as considerably reducing oxidative stress and DNA damage. Other genes expressed by irisin also assist in the fat browning process, such as TMEM26, ELOVL3, CIDEa and COX7a. Regarding the age variant, the SARS-CoV-2 Spike protein benefits from the high concentration of angiotensin-converting enzyme 2 (ACE2) receptors, present in elderly pulmonary alveoli, which bind to the airway and enable contagion. However, ACE2 is negatively regulated by Tribbles homolog 3 (TRIB3) protein from its connection to the nucleocapsid protein of the virus, generating some protection for the individual when TRIB3 is at satisfactory levels. In elderly men, this protein is below normal levels, making this population more vulnerable to SARS-CoV-2 infection. Moreover, it was verified that irisin’s weekly synthesis promoted by regular physical exercises triples TRIB3 levels in pulmonary alveoli. In short, this hormone was able to negatively modulate two important risk factors related to the inflammatory profile of this elderly population (weight and age), and thus irisin should be considered a potential molecule in the prevention against Covid-19.
- 1 May 2021
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 5 (Supplement) , A502-A503
Open AccessFavorable Prognostics of Post-Exercise Irisine Released as Prophylaxis of Serious Covid-19 in Obese Elderly
Studies sought epidemiological profiles to establish risk groups for Covid-19’s evolution and discovered that the age group above 65 years old is one of the most severely affected, due to the presence of other comorbidities. In the USA approximately 55 million individuals are above that age range and more than 23 million are elderly obese individuals, alongside the high mortality rate in this population and lack of proven effective medicine against Covid-19, therapeutic alternatives against this disease are sought. With the occurrence of inflammatory pulmonary conditions increased by SARS-Cov-2 infection, irisin was indicated as having a potential preventive action. This peptide is secreted endogenously by striated skeletal muscles with fibronectin type III domain-containing protein 5 (FNDC5) proteolysis, when preceded by continued exercise of low to moderate intensity for more than 20 uninterrupted minutes. Regarding the weight variant, previous studies showed low levels of FNDC5 in people with excess fatty acids (in humans, adipose tissue divides into white, favoring the deposit of lipids, triglycerides and fat, more easily inflamed, and brown that stimulates thermogenesis). Among other functions, FNDC5 also stimulates the coactivator 1-alpha of PPAR gamma (PGC-1α) which corroborates with the uncoupling between the Uncoupling Protein 1 (UCP1) and the mitochondria. When UCP1 is disincorporated from this organelle, it becomes active and inhibits ATP synthesis, releasing heat, as well as favoring fatty acid oxidation and provides the mechanism of browning of white fat. After this conversion, irisin reduces ¼ of lipid accumulation present in the adipocyte by lipolysis, significantly increasing the levels of serum triglycerides and glycerols, as well as considerably reducing oxidative stress and DNA damage. Other genes expressed by irisin also assist in the fat browning process, such as TMEM26, ELOVL3, CIDEa and COX7a. Regarding the age variant, the SARS-CoV-2 Spike protein benefits from the high concentration of angiotensin-converting enzyme 2 (ACE2) receptors, present in elderly pulmonary alveoli, which bind to the airway and enable contagion. However, ACE2 is negatively regulated by Tribbles homolog 3 (TRIB3) protein from its connection to the nucleocapsid protein of the virus, generating some protection for the individual when TRIB3 is at satisfactory levels. In elderly men, this protein is below normal levels, making this population more vulnerable to SARS-CoV-2 infection. Moreover, it was verified that irisin’s weekly synthesis promoted by regular physical exercises triples TRIB3 levels in pulmonary alveoli. In short, this hormone was able to negatively modulate two important risk factors related to the inflammatory profile of this elderly population (weight and age), and thus irisin should be considered a potential molecule in the prevention against Covid-19.
- Open Access
- 1 January 2021
- Published by Zeppelini Editorial e Comunicacao
- p. 127
Paradoxical neuroplasticity due to post-Covid-19 astrocytosis in children and adolescents
Background: According to the American Academy of Pediatrics, there are approximately 3.28 millions of SARS-CoV-2 infections among children and adolescents as of March 2021. A modulation of the synaptic environment has been described due to astrocytosis caused by SARS-CoV-2 along with a decrease in cognitive stimuli aggravated by social isolation. Objectives: To correlate the slowness of brain connectivity with astrocytosis caused by SARS-CoV-2 in the pediatric population in post-Covid-19. Methods: Literary review carried out at PubMed from January to April 2021, using “Brain infection”, “SARS-CoV-2”, “Children’’, and “Astrocytosis” as descriptors. It was selected 183 articles in english published in the last 5 years, of which only 10 were closer to the research subject. Results: SARS-CoV-2 led by the Spike protein of the virus causes remodeling in glucose metabolism, causing deviation in the consumption of lactate (metabolic substrate of astrocytes), compensatorily way to neuronal malnutrition. To supply their metabolism, astrocytes are taken to a glutamate consumption responsible for synaptic plasticity due to dopamine synthesis (DA). Furthermore, astrocytosis stimulates apoptosis of SH-SY5Y cells, which are linked to dopaminergic expression in synaptic clefts, further accentuating the decline in DA levels. Conclusions: Cortical dysfunctions resulting from neural malnutrition and low cognitive stimulation during social isolation favor an intense neuroplastic paradox in the pediatric population during the critical period.
- 1 January 2021
- Published by Zeppelini Editorial e Comunicacao
- p. 127
Open AccessParadoxical neuroplasticity due to post-Covid-19 astrocytosis in children and adolescents
Background: According to the American Academy of Pediatrics, there are approximately 3.28 millions of SARS-CoV-2 infections among children and adolescents as of March 2021. A modulation of the synaptic environment has been described due to astrocytosis caused by SARS-CoV-2 along with a decrease in cognitive stimuli aggravated by social isolation. Objectives: To correlate the slowness of brain connectivity with astrocytosis caused by SARS-CoV-2 in the pediatric population in post-Covid-19. Methods: Literary review carried out at PubMed from January to April 2021, using “Brain infection”, “SARS-CoV-2”, “Children’’, and “Astrocytosis” as descriptors. It was selected 183 articles in english published in the last 5 years, of which only 10 were closer to the research subject. Results: SARS-CoV-2 led by the Spike protein of the virus causes remodeling in glucose metabolism, causing deviation in the consumption of lactate (metabolic substrate of astrocytes), compensatorily way to neuronal malnutrition. To supply their metabolism, astrocytes are taken to a glutamate consumption responsible for synaptic plasticity due to dopamine synthesis (DA). Furthermore, astrocytosis stimulates apoptosis of SH-SY5Y cells, which are linked to dopaminergic expression in synaptic clefts, further accentuating the decline in DA levels. Conclusions: Cortical dysfunctions resulting from neural malnutrition and low cognitive stimulation during social isolation favor an intense neuroplastic paradox in the pediatric population during the critical period.